Evaluation of the Efficacy and Safety of Administering Lidocaine Spray in Oesophago-gastro-duodenoscopy

• Status: Completed
• Trial end date: 2017-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the efficacy and safety of the administration of lidocaine spray in oesophago-gastro-duodenoscopies. Half of the patients will receive lidocaine spray, while the other half will receive a placebo.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Basque Health Service
• Treatments: Lidocaine

Criteria

Inclusion criteria:

• Patients aged over 18

• ASA I, II and III

• Non allergic to lidocaine or any of the drugs used in the study

• Consent form signed by the patient

Exclusion Criteria:

• Stomach or esophagus diagnosed cancer

• Giant hiatal hernia diagnosed

• Zenker's diverticulum diagnosed

• Achalasia diagnosed

• Patients aged over 70

• Medical history of moderate to severe liver disease

• Medical history of moderate to severe renal insufficiency

• Medical history of moderate to severe Obstructive Sleep Apnea Syndrome (OSA) (AHI≥15).

• Severe respiratory insufficiency(asmtha or COPD) diagnosed

• Patients with encephalopaty active

• Patients with medical history of methemoglobinemia

• Patients with history of drug abuse

• Patients with mental impairment

• Patients with BMI≥ 35

• Use of pediatric tube